Skip to Main content
New interface
Number of documents



Journal articles14 documents

  • Luana C. Mathieu, Prabhjot Singh, Wuelton Marcelo Monteiro, Magda Magris, Horace Cox, et al.. Kelch13 mutations in Plasmodium falciparum and risk of spreading in Amazon basin countries. Journal of Antimicrobial Chemotherapy, 2021, 76 (11), pp.2854-2862. ⟨10.1093/jac/dkab264⟩. ⟨hal-03429601⟩
  • Maylis Douine, Yann Lambert, Muriel Suzanne Galindo, Louise Mutricy, Alice Sanna, et al.. Self-diagnosis and self-treatment of malaria in hard-to-reach and mobile populations of the Amazon: results of Malakit, an international multicentric intervention research project.. The Lancet Regional Health - Americas, 2021, pp.100047. ⟨10.1016/j.lana.2021.100047⟩. ⟨hal-03430898⟩
  • Guillaume Odonne, Lise Musset, C. Cropet, B. Philogene, M. Gaillet, et al.. When local phytotherapies meet biomedicine. Cross-sectional study of knowledge and intercultural practices against malaria in Eastern French Guiana. Journal of Ethnopharmacology, 2021, 279, pp.114384. ⟨10.1016/j.jep.2021.114384⟩. ⟨hal-03429592⟩
  • Luana Mathieu, Horace Cox, Angela M Early, Sachel Mok, Yassamine Lazrek, et al.. Local emergence in Amazonia of Plasmodium falciparum k13 C580Y mutants associated with in vitro artemisinin resistance.. eLife, 2020, 12, pp.e51015. ⟨10.7554/eLife.51015⟩. ⟨hal-02862736⟩
  • Emilie Mosnier, Emmanuel Roux, Claire Cropet, Yassamine Lazrek, Olivier Moriceau, et al.. Prevalence of Plasmodium spp. in the Amazonian Border Context (French Guiana–Brazil): Associated Factors and Spatial Distribution. American Journal of Tropical Medicine and Hygiene, 2020, 102 (1), pp.130-141. ⟨10.4269/ajtmh.19-0378⟩. ⟨hal-02397337⟩
  • Emilie Mosnier, Laure Garancher, M. Galindo, Félix Djossou, Olivier Moriceau, et al.. Paludisme en Guyane : des projets de recherche opérationnelle originaux s'appuyant sur la santé communautaire. La Lettre de l'Infectiologue, 2020, Tome XXXV (2), Online ahead of print. ⟨inserm-03098603⟩
  • Lise Musset, Christophe Heugas, Richard Naldjinan, Denis Blanchet, Pascal Houzé, et al.. Emergence of Plasmodium vivax Resistance to Chloroquine in French Guiana. Antimicrobial Agents and Chemotherapy, 2019, 63 (11), ⟨10.1128/AAC.02116-18⟩. ⟨pasteur-02567258⟩
  • Christophe Le Clorennec, Yassamine Lazrek, Olivier Dubreuil, Carla Sampaio, Christel Larbouret, et al.. ITCH-dependent proteasomal degradation of c-FLIP induced by the anti-HER3 antibody 9F7-F11 promotes DR5/caspase 8-mediated apoptosis of tumor cells. Cell Communication and Signaling, 2019, 17 (1), pp.106-122. ⟨10.1186/s12964-019-0413-8⟩. ⟨inserm-02280785⟩
  • Christophe Le Clorennec, Hervé Bazin, Olivier Dubreuil, Christel Larbouret, Charline Ogier, et al.. Neuregulin 1 Allosterically Enhances the Antitumor Effects of the Noncompeting Anti-HER3 Antibody 9F7-F11 by Increasing Its Binding to HER3. Molecular Cancer Therapeutics, 2017, 16 (7), pp.1312-1323. ⟨10.1158/1535-7163.MCT-16-0886⟩. ⟨hal-02434070⟩
  • Maylis Douine, Emilie Mosnier, Quentin Le Hingrat, Charlotte Charpentier, Florine Corlin, et al.. Illegal gold miners in French Guiana: a neglected population with poor health. BMC Public Health, 2017, 18 (1), pp.23. ⟨10.1016/S0140-6736(10)62169-1⟩. ⟨inserm-01566314⟩
  • Maylis Douine, Y Lazrek, D. Blanchet, S. Pelleau, R Chanlin, et al.. Predictors of antimalarial self-medication in illegal gold miners in French Guiana: a pathway towards artemisinin resistance.. Journal of Antimicrobial Chemotherapy, 2017, Epub ahead of print. ⟨10.1093/jac/dkx343⟩. ⟨inserm-01622957⟩
  • Maylis Douine, Lise Musset, Florine Corlin, Stéphane Pelleau, Yassamine Lazrek, et al.. Paludisme et orpaillage illégal en Guyane : un enjeu majeur de santé publique. Bulletin Epidémiologique Hebdomadaire - BEH, 2017, 6, pp.102-114. ⟨inserm-01491193⟩
  • Christophe Le Clorennec, Yassamine Lazrek, Olivier Dubreuil, Christel Larbouret, Marie-Alix Poul, et al.. The anti-HER3 (ErbB3) therapeutic antibody 9F7-F11 induces HER3 ubiquitination and degradation in tumors through JNK1/2- dependent ITCH/AIP4 activation. Oncotarget, 2016, 7 (24), pp.37013-37029. ⟨10.18632/oncotarget.9455⟩. ⟨hal-02297403⟩
  • Yassamine Lazrek, Olivier Dubreuil, Véronique Garambois, Nadège Gaborit, Christel Larbouret, et al.. Anti-HER3 domain 1 and 3 antibodies reduce tumor growth by hindering HER2/HER3 dimerization and AKT-induced MDM2, XIAP, and FoxO1 phosphorylation.: Anti-HER3 antibodies in cancer therapy. Neoplasia, 2013, 15 (3), pp.335-47. ⟨10.1593/neo.121960⟩. ⟨inserm-00815985⟩

Patents2 documents

  • Yassamine Lazrek, Thierry Chardès, Christel Larbouret, André Pèlegrin. ANTI-HUMAN-HER3 ANTIBODIES AND USES THEREOF. France, Patent n° : WO 2012/156532. 2012. ⟨hal-03706426⟩
  • Yassamine Lazrek. The invention relates to antibodies against HER3 and their use in the treatment of cancer.. France, Patent n° : WO 2012/156309. 2012. ⟨hal-03706393⟩